Scenic Biotech
Amsterdam
About Scenic Biotech
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $41.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: scenicbiotech.com
- Phone: [email protected]
Industries & Categories
Biometrics, Biotechnology, Collaborative Consumption, Life Science
Social Profiles
Canonical: https://fsome.com/organization/scenic-biotech-75216 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.